Faranesh Anthony Z, Nastley Monet T, Perez de la Cruz Cristina, Haller Michael F, Laquerriere Patrice, Leong Kam W, McVeigh Elliot R
Department of Biomedical Engineering, The Johns Hopkins University, Baltimore, Maryland, USA.
Magn Reson Med. 2004 Jun;51(6):1265-71. doi: 10.1002/mrm.20092.
A drug delivery vehicle was constructed that could be visualized noninvasively with MRI. The biodegradable polymer poly(DL-lactic-co-glycolic acid) (PLGA) was used to fabricate microspheres containing vascular endothelial growth factor (VEGF) and the MRI contrast agent gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA). The microspheres were characterized in terms of size, drug and contrast agent encapsulation, and degradation rate. The PLGA microspheres had a mean diameter of 48 +/- 18 microm. The gadolinium loading was 17 +/- 3 microg/mg polymer and the VEGF loading was 163 +/- 22 ng/mg polymer. Electron microscopy revealed that the Gd was dispersed throughout the microspheres and it was confirmed that the Gd loading was sufficient to visualize the microspheres under MRI. VEGF and Gd-DTPA were released from the microspheres in vitro over a period of approximately 6 weeks in three phases: a burst, followed by a slow steady-state, then a rapid steady-state. Biodegradable Gd-doped microspheres can be effectively used to deliver drugs in a sustained manner, while being monitored noninvasively with MRI.
构建了一种可通过磁共振成像(MRI)进行无创可视化的药物递送载体。使用可生物降解的聚合物聚(DL-乳酸-乙醇酸)(PLGA)制备了含有血管内皮生长因子(VEGF)和MRI造影剂钆二乙三胺五乙酸(Gd-DTPA)的微球。对微球的大小、药物和造影剂包封情况以及降解速率进行了表征。PLGA微球的平均直径为48±18微米。钆负载量为17±3微克/毫克聚合物,VEGF负载量为163±22纳克/毫克聚合物。电子显微镜显示钆分散在整个微球中,并且证实钆负载量足以在MRI下使微球可视化。VEGF和Gd-DTPA在体外约6周的时间内分三个阶段从微球中释放:突发阶段,随后是缓慢的稳态阶段,然后是快速的稳态阶段。可生物降解的掺钆微球可有效地用于持续递送药物,同时通过MRI进行无创监测。